HPS Pharmacies wish to advise that all suppliers are experiencing a supply interruption for trimethoprim products, as follows:

Product ARTG Estimated return date

Trimethoprim 300mg tablets

Alprim® 63518 Mid-January 2023
Triprim® 11009 Early March 2023
Trimethoprim Viatris 338350 Mid-January 2023

Trimethoprim + sulfamethoxazole

Resprim® tablets (80mg/400mg) 17681 Mid December 2022
Resprim® Forte tablets (160mg/800mg) 17682 Early February 2023
Septrin® Forte tablets (160mg/800mg) 10998 Late January 2023
DBL™ Sulfamethoxazole 400mg and Trimethoprim 80mg/5 mL ampoule 16293 Late February 2023

Internationally registered brands of trimethoprim 300mg tablets and sulfamethoxazole and trimethoprim 400mg/80mg ampoules have been approved for supply under Section 19A of the Therapeutic Goods Act 1989.

Septrin® Suspension (trimethoprim + sulfamethoxazole) is not currently affected by this supply interruption.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates